Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | WGS | GH |
|---|---|---|
| Price | $76.27 | $187.22 |
| Change today | ▲ 4.35% | ▲ 5.30% |
| Market cap | $2.27B | $25.12B |
| Return, 3 months | +16.6% | +14.9% |
| Return, year to date | -41.4% | +83.3% |
| Return, 1 year | -36.5% | +195.4% |
| P/E (TTM) | -21.1 | -53.3 |
| P/B | 9.3 | -112.7 |
| P/E percentile vs own 5y | 24th | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +40.0% | +44.3% |
| Net profit growth (YoY) | +59.8% | -20.3% |
| Gross margin | 69.7% | 65.0% |
| Operating margin | -3.1% | -39.7% |
| Net margin | -4.9% | -38.3% |
| Return on equity | – | – |
| Analyst target vs. price | +20.8% | +7.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 42 | 67 |
| 30-day volatility | 67.4% | 42.7% |
| Max drawdown, 1 year | -79.4% | -33.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
